TREND INNOVATIONS RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHWed, 08 Apr 2026 22:04:45 +0200https://images.finanzen.net/images/finanzen_net_neu.gifTREND INNOVATIONS RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netBeyond Insulin Pumps: Cell Therapies Unlock a $403B Cure EconomyTue, 16 Dec 2025 17:53:00 +0100https://www.finanzen.net/nachricht/aktien/beyond-insulin-pumps-cell-therapies-unlock-a-403b-cure-economy-15362933

Issued on behalf of Avant Technologies Inc.

]]>https://www.finanzen.net/nachricht/aktien/beyond-insulin-pumps-cell-therapies-unlock-a-403b-cure-economy-15362933Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure EconomyTue, 16 Dec 2025 17:53:00 +0100https://www.finanzen.net/nachricht/aktien/beyond-insulin-pumps-cell-therapies-unlock-a-403b-cure-economy-15362935

Issued on behalf of Avant Technologies Inc.

]]>https://www.finanzen.net/nachricht/aktien/beyond-insulin-pumps-cell-therapies-unlock-a-403b-cure-economy-15362935Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes TreatmentTue, 16 Dec 2025 14:15:00 +0100https://www.finanzen.net/nachricht/aktien/avant-technologies-highlights-the-critical-role-of-cell-encapsulation-technology-in-revolutionizing-diabetes-treatment-15361856

LAS VEGAS, Dec. 16, 2025 /CNW/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an ...

]]>https://www.finanzen.net/nachricht/aktien/avant-technologies-highlights-the-critical-role-of-cell-encapsulation-technology-in-revolutionizing-diabetes-treatment-15361856Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes TreatmentTue, 16 Dec 2025 14:15:00 +0100https://www.finanzen.net/nachricht/aktien/avant-technologies-highlights-the-critical-role-of-cell-encapsulation-technology-in-revolutionizing-diabetes-treatment-15361858

LAS VEGAS, Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), ...

]]>https://www.finanzen.net/nachricht/aktien/avant-technologies-highlights-the-critical-role-of-cell-encapsulation-technology-in-revolutionizing-diabetes-treatment-15361858Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat ConditionsTue, 09 Dec 2025 17:57:00 +0100https://www.finanzen.net/nachricht/aktien/beyond-traditional-drugs-novel-platforms-targeting-hard-to-treat-conditions-15346823

Issued on behalf of Avant Technologies Inc.

VANCOUVER, BC, Dec. ...

]]>https://www.finanzen.net/nachricht/aktien/beyond-traditional-drugs-novel-platforms-targeting-hard-to-treat-conditions-15346823Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat ConditionsTue, 09 Dec 2025 17:57:00 +0100https://www.finanzen.net/nachricht/aktien/beyond-traditional-drugs-novel-platforms-targeting-hard-to-treat-conditions-15346826

Issued on behalf of Avant Technologies Inc.

VANCOUVER, BC, Dec. ...

]]>https://www.finanzen.net/nachricht/aktien/beyond-traditional-drugs-novel-platforms-targeting-hard-to-treat-conditions-15346826Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular SurvivalTue, 09 Dec 2025 14:30:00 +0100https://www.finanzen.net/nachricht/aktien/avant-technologies-and-austrianova-advancing-α-klotho-cell-therapy-as-mayo-clinic-study-links-low-α-klotho-levels-to-poor-cardiovascular-survival-15345766

LAS VEGAS, Dec. 9, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), ...

]]>https://www.finanzen.net/nachricht/aktien/avant-technologies-and-austrianova-advancing-α-klotho-cell-therapy-as-mayo-clinic-study-links-low-α-klotho-levels-to-poor-cardiovascular-survival-15345766Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular SurvivalTue, 09 Dec 2025 14:30:00 +0100https://www.finanzen.net/nachricht/aktien/avant-technologies-and-austrianova-advancing-α-klotho-cell-therapy-as-mayo-clinic-study-links-low-α-klotho-levels-to-poor-cardiovascular-survival-15345755

LAS VEGAS, Dec. 9, 2025 /CNW/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an ...

]]>https://www.finanzen.net/nachricht/aktien/avant-technologies-and-austrianova-advancing-α-klotho-cell-therapy-as-mayo-clinic-study-links-low-α-klotho-levels-to-poor-cardiovascular-survival-15345755Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' KlothoTue, 21 Oct 2025 14:00:00 +0200https://www.finanzen.net/nachricht/aktien/avant-technologies-and-austrianova-launch-klothonova-begin-developing-age-related-cellular-therapies-using-longevity-protein-klotho-15101132

LAS VEGAS, Oct. 21, 2025 /CNW/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company") and ...

]]>https://www.finanzen.net/nachricht/aktien/avant-technologies-and-austrianova-launch-klothonova-begin-developing-age-related-cellular-therapies-using-longevity-protein-klotho-15101132Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' KlothoTue, 21 Oct 2025 14:00:00 +0200https://www.finanzen.net/nachricht/aktien/avant-technologies-and-austrianova-launch-klothonova-begin-developing-age-related-cellular-therapies-using-longevity-protein-klotho-15101173

LAS VEGAS, Oct. 21, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company") ...

]]>https://www.finanzen.net/nachricht/aktien/avant-technologies-and-austrianova-launch-klothonova-begin-developing-age-related-cellular-therapies-using-longevity-protein-klotho-15101173